## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.0% below STRENGTH zone (3.0-6.0%); PEG 3.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($537.98)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Navy Awards Northrop Grumman $334M to Expand Fleet Electronic Warfare Systems**
- Source: Security Clearance Jobs | 20251218T000953 | Bullish | Relevance: 100%
- The Navy awarded Northrop Grumman Systems Corp. a $334 million firm-fixed-price modification for the production of Surface Electronic Warfare Improvement Program (SEWIP) Block 3 Hemisphere and Quadrant systems. If all options are exercised, the contract could reach $783 million and extend work through April 2030. This award, obligated with fiscal 2025 shipbuilding and construction funds, aims to enhance the fleet's electronic warfare capabilities.

**2. Northrop Grumman, 4iG Sign MOU to Expand C-UAS, Space and Weapons Collaboration**
- Source: UAS Magazine | 20251217T143550 | Bullish | Relevance: 100%
- Northrop Grumman and 4iG have signed a Memorandum of Understanding (MOU) to expand their collaboration in counter-unmanned aerial systems (C-UAS), space, and weapons technology. This agreement highlights the increasing focus on advanced defense capabilities. The article features a Northrop Grumman MQ-4C Triton uncrewed aircraft, aligning with Norway's maritime surveillance needs.

**3. Northrop Grumman and 4iG partner on defense tech collaboration**
- Source: Investing.com | 20251216T194406 | Bullish | Relevance: 100%
- Northrop Grumman Corporation and 4iG Space and Defence Technologies Ltd. have signed a Memorandum of Understanding (MOU) to collaborate on defense technologies including counter-unmanned aerial systems, space, and advanced weapons. This partnership aims to strengthen U.S. technological leadership and Europe’s sovereign defense industrial base while enhancing NATO capabilities through innovation. The agreement highlights the growing defense relationship between the United States and Hungary.

**4. Northrop Grumman begins production of Bushmaster guns for Marine Corps By Investing.com**
- Source: Investing.com UK | 20251216T140822 | Bullish | Relevance: 100%
- Northrop Grumman has initiated full-rate production of its Mk44 Stretch Bushmaster Chain Guns for the U.S. Marine Corps' Amphibious Combat Vehicle (ACV) program. These guns will be integrated into Kongsberg remote turrets on the ACV-30, enhancing the Marines' firepower and adaptability with features like the ability to convert between 30mm and 40mm calibers. The production is taking place at Northrop Grumman’s facility in Mesa, Arizona, aiming to provide superior combat capabilities with advanced ammunition compatibility.

**5. General Dynamics, L3Harris upgraded at Morgan Stanley; Lockheed Martin downgraded**
- Source: Seeking Alpha | 20251216T160822 | Bullish | Relevance: 73%
- Morgan Stanley issued an "Attractive" outlook for the North American aerospace and defense sectors for 2026, citing demand outpacing supply growth. The firm's analysis, led by Kristine T. Liwag, includes a re-stacking of ratings with Northrop Grumman and RTX among the top picks due to strong value and growth potential. Conversely, Lockheed Martin was downgraded due to concerns about share price volatility.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.08M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.68 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $80.1B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.68 |
| Forward P/E | 19.4 |
| Current P/E | 21.5 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.2% to 1.0% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.0pp (needs >3.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_10 - short-term weakness emerging. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). MACD histogram positive (2.07), confirming momentum. RSI neutral at 46. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.02% (CS: 50) | Neutral |
| RSI_14 | 46.0 | Neutral |
| MACD Histogram | 2.07 | Bullish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 0.970x | Below |
| vs SMA200 | 1.034x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $559.36
- **Stop Loss:** $537.98 (3.8% risk)
- **Target:** $580.74 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 33
- **Position Value:** $18,458.88
- **Portfolio %:** 18.46%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*